Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study
Author
Ford, Corey C.Cohen, Jeffrey A.
Goodman, Andrew D.
Lindsey, John W.
Lisak, Robert P.
Luzzio, Christopher
Pruitt, Amy
Rose, John
Rus, Horea
Wolinsky, Jerry S.
Kadosh, Shaul E.
Bernstein-Hanlon, Emily
Stark, Yafit
Alexander, Jessica K.
Date
2022-01-01Journal
Multiple Sclerosis JournalPublisher
SAGE Publications Inc.Type
Article
Metadata
Show full item recordAbstract
Study Design: Modified DELPHI Consensus Process Objective: To agree a single unifying term and definition. Globally, cervical myelopathy caused by degenerative changes to the spine is known by over 11 different names. This inconsistency contributes to many clinical and research challenges, including a lack of awareness. Method: AO Spine RECODE-DCM (Research objectives and Common Data Elements Degenerative Cervical Myelopathy). To determine the index term, a longlist of candidate terms and their rationale, was created using a literature review and interviews. This was shared with the community, to select their preferred terms (248 members (58%) including 149 (60%) surgeons, 45 (18%) other healthcare professionals and 54 (22%) People with DCM or their supporters) and finalized using a consensus meeting. To determine a definition, a medical definition framework was created using inductive thematic analysis of selected International Classification of Disease definitions. Separately, stakeholders submitted their suggested definition which also underwent inductive thematic analysis (317 members (76%), 190 (59%) surgeons, 62 (20%) other healthcare professionals and 72 (23%) persons living with DCM or their supporters). Using this definition framework, a working definition was created based on submitted content, and finalized using consensus meetings. Results: Degenerative Cervical Myelopathy was selected as the unifying term, defined in short, as a progressive spinal cord injury caused by narrowing of the cervical spinal canal Conclusion: A consistent term and definition can support education and research initiatives. This was selected using a structured and iterative methodology, which may serve as an exemplar for others in the future. © The Author(s) 2022.Sponsors
National Institutes of HealthKeyword
Clinical trialdisease-modifying therapies
glatiramer acetate
multiple sclerosis
quality of life
relapsing/remitting
Identifier to cite or link to this item
http://hdl.handle.net/10713/19367ae974a485f413a2113503eed53cd6c53
10.1177/13524585221094239